| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA2114861 | F | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists: Cytotox Screen. (Class of assay: confirmatory) | 26,907 | assay format | PubChem BioAssays | |||
| 2. | ALA2114713 | F | PubChem BioAssay. qHTS Assay for Activators of ClpP. (Class of assay: confirmatory) | Bacillus subtilis | 20,646 | assay format | PubChem BioAssays | ||
| 3. | ALA2114784 | F | PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) | Homo sapiens | 53,810 | assay format | PubChem BioAssays | ||
| 4. | ALA2114788 | F | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | Homo sapiens | 103,470 | assay format | PubChem BioAssays | ||
| 5. | ALA2114931 | F | PubChem BioAssay. qHTS of GLP-1 Receptor Agonists. (Class of assay: confirmatory) | Homo sapiens | 3,540 | assay format | PubChem BioAssays | ||
| 6. | ALA2354211 | F | PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line. (Class of assay: confirmatory) | 35,070 | cell-based format | PubChem BioAssays | |||
| 7. | ALA2354221 | F | PubChem BioAssay. qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT. (Class of assay: confirmatory) | 172,532 | assay format | PubChem BioAssays | |||
| 8. | ALA2354254 | F | PubChem BioAssay. qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT. (Class of assay: confirmatory) | 153,867 | assay format | PubChem BioAssays | |||
| 9. | ALA2354287 | F | PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) | 39,968 | assay format | PubChem BioAssays | |||
| 10. | ALA2354311 | F | PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) | 31,581 | cell-based format | PubChem BioAssays | |||
| 11. | ALA3215017 | F | PubChem BioAssay. qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: mCherry Reporter Primary qHTS. (Class of assay: confirmatory) | 26,949 | assay format | PubChem BioAssays | |||
| 12. | ALA3215242 | F | PubChem BioAssay. Counterscreen for inhibitors of COUP-TFII (NR2F2): Luminescence-based cell-based high throughput dose response assay to identify inhibitors of the Herpes Virus Virion Protein 16 (VP16). (Class of assay: confirmatory) | 232 | cell-based format | PubChem BioAssays | |||
| 13. | ALA3215270 | F | PubChem BioAssay. qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary qHTS. (Class of assay: confirmatory) | 22,758 | assay format | PubChem BioAssays | |||
| 14. | ALA3214816 | F | PubChem BioAssay. Luminescence-based cell-based high throughput dose response assay to identify inhibitors of COUP-TFII (NR2F2). (Class of assay: confirmatory) | 232 | cell-based format | PubChem BioAssays | |||
| 15. | ALA3562077 | F | PubChem BioAssay. High Throughput Screening for Foot and Mouth Disease Virus Antivirals. (Class of assay: confirmatory) | 69,295 | assay format | PubChem BioAssays |
The page will load shortly, Thanks for your patience!